BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12454519)

  • 1. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.
    Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S
    Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
    Lygidakis NJ; Stringaris K
    Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?
    Sasson AR; Hoffman JP; Ross EA; Kagan SA; Pingpank JF; Eisenberg BL
    J Gastrointest Surg; 2002; 6(2):147-57; discussion 157-8. PubMed ID: 11992799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion. A prospective randomized study.
    Lygidakis NJ; Singh G; Bardaxoglou E; Dedemadi G; Sgourakis G; Nestoridis J; Malliotakis A; Pedonomou M; Solomou EK; Safioleas M; Alamani M; Grigorakos L; Merikas EM
    Hepatogastroenterology; 2004; 51(56):427-33. PubMed ID: 15086174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic resection for pancreatic carcinoma combined with neo- and adjuvant locoregional targeting immuno-chemotherapy--a prospective randomized study.
    Lygidakis NJ; Spentzouris N; Theodoracopoulos M; Dedemadi G; Gemos K; Kyriakou A
    Hepatogastroenterology; 1998; 45(20):396-403. PubMed ID: 9638413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.
    Kagedan DJ; Abraham L; Goyert N; Li Q; Paszat LF; Kiss A; Earle CC; Mittmann N; Coburn NG
    Cancer; 2016 Oct; 122(20):3175-3182. PubMed ID: 27391466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
    Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
    Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
    Lygidakis NJ; Papadopoulou P
    Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
    Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
    J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
    Lim JE; Chien MW; Earle CC
    Ann Surg; 2003 Jan; 237(1):74-85. PubMed ID: 12496533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Cancer Surgery: The New R-status Counts.
    Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
    Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.
    Perinel J; Nappo G; El Bechwaty M; Walter T; Hervieu V; Valette PJ; Feugier P; Adham M
    Langenbecks Arch Surg; 2016 Dec; 401(8):1131-1142. PubMed ID: 27476146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
    Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
    Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
    Khan M; Ashraf MI; Syed AA; Hanif F
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.